![](/cdn/assets/images/search/clock.png)
We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, an... Vir Biotechnology Inc is a commercial-stage immunology company focused on treating and preventing infectious diseases. It has four technology platforms, focused on antibodies, T cells, innate immunity, and small interfering ribonucleic acid, or siRNA, through internal development, collaborations, and acquisitions. The company's pipeline consists of product candidates targeting hepatitis B virus, or HBV, influenza A, human immunodeficiency virus, or HIV, and tuberculosis, or TB. Its revenue sources are collaboration revenue, contract revenue, grant revenue and license revenue. Show more
Vir Biotechnology, Inc. (Nasdaq: VIR) today announced the Company will provide financial results for the second quarter ended June 30, 2024, on August 1, 2024. The Company will host a conference...
Fast Track designation follows positive preliminary Phase 2 trial data presented at the European Association for the Study of the Liver Congress 2024 and underscores the unmet need for people...
– Preliminary Phase 2 SOLSTICE trial data reinforce the potential of both regimens to be transformative treatments in an area of high unmet medical need – – Conference call scheduled for June 5...
Period | Change | Change % | Open | High | Low | Avg. Daily Vol | VWAP | |
---|---|---|---|---|---|---|---|---|
1 | 0.63 | 6.70212765957 | 9.4 | 10.56 | 9.31 | 1001512 | 10.10573483 | CS |
4 | 0.85 | 9.25925925926 | 9.18 | 10.56 | 8.25 | 1021095 | 9.22200593 | CS |
12 | 1.72 | 20.697954272 | 8.31 | 13.09 | 8.2 | 1198518 | 9.8825275 | CS |
26 | 0.52 | 5.46792849632 | 9.51 | 13.09 | 7.61 | 1126662 | 9.88467917 | CS |
52 | -4.12 | -29.1166077739 | 14.15 | 14.4497 | 7.61 | 1196236 | 10.09971305 | CS |
156 | -27.74 | -73.4445326979 | 37.77 | 58 | 7.61 | 1185281 | 22.98770807 | CS |
260 | -6.12 | -37.8947368421 | 16.15 | 141.01 | 7.61 | 1131392 | 29.63797212 | CS |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: 1-888-992-3836 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions